Iveric Bio announces FDA approval for IZERVAY™️️
Congratulations to Iveric Bio for their FDA approval for IZERVAY™️️, a new treatment for...
read Details
September 9, 2021: Modality Solutions announced that Sumika Stansbury has joined the company as a Consulting Engineer. Sumika will help biopharmaceutical companies prepare their drug products for the rigors of the cold chain by developing transport validation test protocols, reviewing test validation data, and writing the comprehensive technical reports they rely on for successful regulatory filings.
“Her experience in chemical engineering, coupled with her strengths in team-building, project management, and client service, was a real differentiator,” said Modality Solutions President, Gary Hutchinson.
Click here to view the online press release announcement.
Congratulations to Iveric Bio for their FDA approval for IZERVAY™️️, a new treatment for...
read DetailsCongratulations to Incyte on their FDA approval for Zynyz™, a treatment for adults with metastatic...
read DetailsCongratulations to Amicus Therapeutics for their European Commission approval for Pombiliti™ in patients with Late-Onset...
read Details